Upon binding, it induces an elevated cytotoxic T-lymphocyte response on tumor cells, and MUC1–chimeric antigen receptor T cells show target-specific cytotoxicity and tumor inhibition in pancreatic cancer xenograft models (Cai et al., 2015). Here, MUC1 is linked to pancreatic neoplasm.